Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 OverviewCyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 Net Income
Profitability analysis for CYCCP.
Quarterly Net Income
-$197.00
↓ 143.21% YoY
As of Mar 2026
Annual Net Income (TTM)
-$1.60M
↑ 47.62% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...